Abiopharma

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0000950103-26-006726 <b>Size:</b> 346 KB

Results of the general meeting from 4.5.26

Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division

New Form FWP - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001193125-26-203142 <b>Size:</b> 399 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001839882-26-022692 <b>Size:</b> 937 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001140361-26-018758 <b>Size:</b> 357 KB

CACI Appoints Christopher Monoski as Executive Vice President, Manufacturing

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011896 <b>Size:</b> 549 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011895 <b>Size:</b> 827 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001839882-26-022687 <b>Size:</b> 1 MB

New Form 3 - CATERPILLAR INC <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001104659-26-054593 <b>Size:</b> 100 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001839882-26-022686 <b>Size:</b> 782 KB

Results of special meeting dated 4.5.26 - approval of granting a grant to the company CEO

EVERYWHERE Communications Partners with Parsons to Enable Resilient, Beyond-Line-of-Sight Autonomous Drone Operations Under SBIR Initiative

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001193125-26-203111 <b>Size:</b> 323 KB